Ohio Governor Mike DeWine has signed a new pro-life bill into law that will help save babies from abortions. The Ohio legislature approved a pro-life bill to ban a dangerous form of abortions that kill unborn babies but also put women’s health at risk.
Senate Bill 260, the Telemedicine Abortion Ban, passed out of the Ohio House of Representatives by a vote of 54 to 30. This legislation, spearheaded by Ohio Right to Life and Senator Steve Huffman, a physician, would prohibit the use of telemedicine for the purpose of selling abortion-inducing drugs and ensure that these killer drugs could only be provided in-person by the prescribing physician.
The Telemedicine Abortion Ban was introduced in January of 2020. During opponent testimony on SB 260, it came to light that Planned Parenthood had been committing abortions in Ohio using a form of telemedicine for several years. The total number of telemedicine abortions committed in Ohio by Planned Parenthood remains unknown, as they have yet to make the current statistics public.
“Ohio Right to Life is immensely grateful to our governor and our pro-life legislature for their work in ensuring that this much-needed protection became a part of Ohio law,” said Ohio Right to Life president Mike Gonidakis. “Although every chemical abortion is a tragedy than ends a baby’s life, this law helps prevent further loss of life by protecting women from an abortion industry which puts profits before safety. Planned Parenthood’s use of telemedicine to dispense abortion-inducing drugs cuts their own costs at the expense of basic health and safety standards. Patient safety shouldn’t have a price tag. Women deserve better.”
“The signing of the Telemedicine Abortion Ban into law is a victory for life and for women’s safety,” said Gonidakis. “No woman should be subjected to a dangerous telemedicine abortion in order to pad Planned Parenthood’s pockets. Pro-Life Ohio will not let the abortion industry continue to treat vulnerable women and children as money-making opportunities. Women and children deserve to be put first. This law is a crucial step towards that end.”
REACH PRO-LIFE PEOPLE WORLDWIDE! Advertise with LifeNews to reach hundreds of thousands of pro-life readers every week. Contact us today.
The abortion pills are dangerous to women.
The first pill in the chemical abortion pill regimen, mifepristone, is highly regulated by the FDA due to safety concerns. The FDA recorded nearly 4,200 adverse events from mifepristone between 2012 and 2018 and over 1,000 of those cases required hospitalization. Since the abortion pill regimen was first introduced in the U.S. in 2000, 24 women have died from chemical abortion complications.
Historically, Mifeprex, which comprises the first pill in the abortion pill regimen, has been highly regulated by the FDA, to the extent that they have imposed special safety requirements called Risk Evaluation and Mitigation Strategies (REMS) on the drug to reduce patient risk. Between 2012 to 2018 alone, the FDA recorded 4,195 cases of women being injured by the abortion pill. Twenty-four women have died from Mifeprex since the abortion pill was first introduced in the U.S. in 2000.
“Although every successful abortion is a tragedy which results in the ending of a human life,” says Senator Steve Huffman, “abortions committed through telemedicine have the potential to add one tragedy to another by subjecting women to dangerous abortions-inducing drugs without providing basic health and safety standards. Planned Parenthood may consider the financial boost of telemedicine abortion worth the very real risk to women’s lives, but as a physician, I certainly do not.”
Non-surgical abortions continue to make up a greater proportion of abortions performed in Ohio each year. In 2018, the [two-drug] Mifeprex regimen was used to perform 6,103 abortions, or approximately 30% of all abortions that year, and is the most commonly reported method of abortion before 10 weeks gestation.
